Zenas Biopharma(ZBIO.US)

Company Encyclopedia
View More
name
Zenas Biopharma
ZBIO.US
Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc?RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company also develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; and ZB001, an anti-IGF-1R monoclonal antibody. The company was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc.
1.960 T
ZBIO.USMarket value -Rank by Market Cap -/-

Financial Score

08/01/2026 Update
D
BiotechnologyIndustry
Industry Ranking218/398
Industry medianC
Industry averageD
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-68.33%E
    • Profit Margin-1265.99%E
    • Gross Margin0.00%E
  • Growth ScoreD
    • Revenue YoY0.00%C
    • Net Profit YoY-47.24%D
    • Total Assets YoY-20.18%E
    • Net Assets YoY-45.35%E
  • Cash ScoreD
    • Cash Flow Margin-7.90%D
    • OCF YoY0.00%C
  • Operating ScoreE
    • Turnover0.04E
  • Debt ScoreB
    • Gearing Ratio39.00%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    U.S. stock market midday update: Zenas Biopharma plummets 13.12%, with a surge in trading volume attracting market attention

    Zenas Biopharma fell 13.12%; AbbVie rose 0.62%, with a transaction volume of USD 619 million; Forte Pharma rose 3.90%, with a transaction volume of USD 398 million; Arrowhead Pharmaceuticals rose 8.46%, with a transaction volume of USD 394 million; Amgen rose 1.94%, with a market value of USD 176.1 billion

    Tracking Unusual Activity·
    US
    ZBIO
    +8.62%
    Tracking Unusual Activity·
    US
    ZBIO
    +8.62%

    U.S. stock market movement report: Alumis surges 150%, Mobix Labs plummets 46%, tech stocks trading actively

    Overview of the US Stock Market In the past hour, the US stock market has shown significant sector rotation, with technology and pharmaceutical sectors performing particularly well. Capital flows have clearly favored small-cap stocks and thematic stocks, especially those companies with major news or technological breakthroughs recently. Market sentiment is active, with considerable volatility, and short-term enthusiasm continues to rise. The stock with the largest movement, Alumis, leads the market with a 150.64% increase, and trading volume has significantly expanded, indicating strong investor confidence in its future development. The strong performance of this stock may be related to its innovative breakthroughs in the pharmaceutical field, attracting substantial capital attention. Strong stocks: 1. Autozi Internet Tech Global: up 51.24%, with increased trading volume, driven by the enthusiasm in the technology sector pushing its stock price significantly higher. 2. PMGC: up 31.37%, with noticeable capital inflow, and the market is optimistic about its future growth expectations. 3. Brand Engagement Network: up 29.94%, with active short-term capital and high market sentiment. 4. WAVE Life Sciences: up 27.40%, driven by the strong performance of the pharmaceutical sector pushing its stock price upward. 5. Sky Quarry: up 26.15%, with increased attention on environmental themes driving the stock price up. 6. Banzai: up 22.29%, with increased market recognition of its business model and noticeable capital inflow

    Tracking Unusual Activity·
    US
    ZBIO
    +8.62%
    Tracking Unusual Activity·
    US
    ZBIO
    +8.62%

    Pre-market hot trades in US stocks: Zenas Biopharma pre-market down 8.07%, sector trends causing market fluctuations?

    Zenas Biopharma pre-market down 8.07%; Cyclerion Therapeutics pre-market up 42.03%; Aeva Tech pre-market up 31.47%; VS MEDIA pre-market up 25.45%

    Tracking Unusual Activity·
    US
    ZBIO
    +8.62%
    Tracking Unusual Activity·
    US
    ZBIO
    +8.62%

    U.S. Stock Market Movement Update: Kala Bio leads with a 20% increase, biotech stocks are active, Redhill Biopharma drops 9%

    Market Overview of US Stocks in the Last Hour The US stock market has shown a significant sector rotation in the last hour, with the pharmaceutical and technology sectors performing particularly well. Capital flows are concentrated in small-cap stocks and thematic stocks, with high short-term enthusiasm. The overall market pace is fast, with large fluctuations, and investor sentiment is active. The stock with the largest movement in the last hour, Kala Pharmaceuticals, rose by 20.13%, becoming the most eye-catching stock during this period. A large influx of funds has driven the stock price to rise rapidly, with high short-term sentiment. Strong stocks: 1. Innoviz Tech: up 17.07%, the strong performance of the technology sector has driven the stock's rise, with active short-term capital involvement. 2. Nine Energy: up 11.22%, the recovery of the energy sector has significantly benefited this stock, with notable capital inflows. 3. Cue BioPharma: up 9.51%, the overall strength of the pharmaceutical sector has driven the stock's rise, with increased market attention. 4. Novonix: up 9.38%, the enthusiasm for new energy themes remains high, with continuous short-term capital inflows. 5. Sky Quarry: up 9.29%, the active performance of environmental concept stocks has driven the stock's rise. 6. Semilux: up 8.71%, the strong performance of the semiconductor sector has benefited this stock, with significant capital inflows. 7. Kosmos Energy: up 8.08%, the overall recovery of the energy sector has driven the stock's rise

    Tracking Unusual Activity·
    US
    ZBIO
    +8.62%
    Tracking Unusual Activity·
    US
    ZBIO
    +8.62%

    U.S. Stock Movement Update: Kala BioPharma leads with a 23% increase, energy stocks are active, Wing Yip Food drops 9%

    Market Overview of US Stocks in the Last Hour The US stock market has shown a significant sector rotation in the past hour, with the pharmaceutical and energy sectors performing particularly well. Small-cap stocks and thematic stocks have seen concentrated gains, with funds gradually shifting their preference towards these sectors. The overall market rhythm is fast-paced, with considerable volatility and a noticeable increase in short-term enthusiasm. The most notable stock in the last hour is Kala Pharmaceuticals, which surged by 23.10%. Driven by the pharmaceutical sector, short-term funds have flowed in, pushing the stock price up rapidly. Strong stocks: 1. Nine Energy: up 12.12%, driven by the strong performance of the energy sector, with active short-term funds. 2. Semilux: up 10.57%, performing excellently under the influence of the technology sector, with significant fund inflow. 3. Novonix: up 10.16%, benefiting from the sustained enthusiasm in the new energy sector. 4. Cue BioPharma: up 9.51%, boosted by the strong performance of the pharmaceutical sector. 5. Bakkt: up 9.47%, with increased enthusiasm for digital currency-related themes driving the stock up. 6. Sky Quarry: up 9.39%, with rising attention to environmental themes and significant fund inflow. 7. Kosmos Energy: up 8.08%, driven by the overall strength of the energy sector

    Tracking Unusual Activity·
    US
    ZBIO
    +8.62%
    Tracking Unusual Activity·
    US
    ZBIO
    +8.62%
    © 2026 Longbridge｜Disclaimer